Epilepsy News

For the first time since 2010, the National Association of Epilepsy has issued revised care guidelines, with a focus on precision in patient evaluation, diagnostics and multidisciplinary intervention as needed.

Surgical procedures targeting vagus nerve stimulation for those with drug-resistant epilepsy are generally safe with low incidence and rate of complications, according to research from Brain and Spine.

Caregivers for those with Lennox Gastaut and Dravet syndrome reported that cannabidiol treatment led to improved nonseizure outcomes and reduced seizure burden, according to a study from Epilepsy Research.

A clinical-stage biopharmaceutical company has announced positive topline data from a study evaluating a novel, oral 5-HT2C receptor superagonist for seizures associated with developmental and epileptic encephalopathies.

ORLANDO — While effective medications for epilepsy exist, scientific advancement requires that future gene-targeting therapies or cures benefit the largest number of patients while overcoming several barriers, according to a presentation.

AbbVie Inc. has acquired Cerevel Therapeutics and its pipeline of clinical stage and preclinical neuroscience candidates in development to address conditions such as Parkinson’s disease, schizophrenia and mood disorders.

ORLANDO — Although effective treatments have been established for those with epilepsy, there is a need for more and novel therapies, which face barriers of efficacy and access, according to a presenter.

ORLANDO — Adults with epilepsy who were given medical cannabis recorded a significant decrease in weekly seizure frequency, according to a poster from the American Epilepsy Society annual meeting.

ORLANDO — A home-based mental health program for individuals with epilepsy was effective in detecting symptoms of depression and suicidality, according to a poster.

ORLANDO — Adjunctive treatment with brivaracetam led to significant seizure reduction and seizure freedom in a cohort of adults with focal onset epilepsy, according to interim results of a study.